Download Docs
Export
Print

GYRE

99248264 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed June 23, 2025
Serial No. 99248264
Examining Attorney EVIN L KOZAK
Class Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers; 005; 006; 018; 044; 046; 051; 052; 100; 101
GYRE
Case Type Trademark Service mark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 8 hours ago
Filing Date # Docket Text